Saltar al contenido
Merck

Antimicrobial susceptibilities of clinical isolates of HACEK organisms.

Antimicrobial agents and chemotherapy (2013-02-14)
Bryan Coburn, Baldwin Toye, Prasad Rawte, Frances B Jamieson, David J Farrell, Samir N Patel
RESUMEN

The "HACEK" organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Ceftriaxone disodium salt hemi(heptahydrate), third-generation cephalosporin antibiotic
Supelco
Levofloxacin, analytical standard
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ofloxacin, VETRANAL®, analytical standard
Ceftriaxone sodium, European Pharmacopoeia (EP) Reference Standard
Ofloxacin, European Pharmacopoeia (EP) Reference Standard